Coronary Artery Disease, Diabetes Mellitus
Conditions
Keywords
coronary flow reserve, fractional flow reserve, diabetes mellitus, coronary artery disease, percutaneous coronary intervention, coronary physiology, index of microcirculatory resistance
Brief summary
Comprehensive assessment of coronary physiology (fractional flow reserve (FFR), coronary flow reserve (CFR) and index of microcirculatory resistance (IMR)) in patients with diabetes mellitus and coronary artery disease (CAD).
Detailed description
Background: There is currently no data on invasive measurement of FFR, CFR and IMR in patients with diabetes mellitus. Studies such as RIPCORD has shown that using coronary angiography alone to guide revascularization strategy may be flawed in a significant proportion of patients. Patients with diabetes mellitus are more likely to have diffuse CAD and microvascular disease. Current recommendation of invasive physiological assessment to guide percutaneous coronary intervention (PCI) is limited to FFR alone. This can be misleading in diffuse coronary artery disease and microvascular disease as both conditions are associated with higher FFR. The proportion of vessels which show discordance between FFR and CFR consistent with diffuse CAD and/or microvascular disease in patients has been shown to be as high as 30% in a study not exclusive to diabetics. This is a pilot study of 50 patients referred for PCI based on angiographic stenosis of ≥50%. Comprehensive physiological assessment will be undertaken in target and non-target vessels to determine the prevalence of discordant FFR and CFR consistent with diffuse CAD and/or microvascular dysfunction in diabetics. Methods: 1. Patients will receive an information sheet after initial invitation to participate in the study. 2. Written informed consent will be obtained. 3. Patients will undergo invasive assessment of FFR, CFR and IMR in non-target vessels. 4. An optical coherence tomography (OCT) study will be performed to correlate physiological parameters with intravascular imaging for diffuse atheromatous disease. 5. Patients will then undergo OCT and invasive assessment of FFR, CFR and IMR in the target vessel pre and post PCI. 6. Any change in FFR, CFR and IMR post PCI will be recorded. 7. All physiological parameters will be measured using the pressure wire from St. Jude Medical, USA (currently, Certus). Results will be grouped according to 4 possible permutations of FFR and CFR.
Interventions
DEVICEPressure Wire Certus, St. Jude Medical, USA
FFR. CFR and IMR will be measured using the Pressure Wire Certus, St. Jude Medical, USA in target and non-target vessels. Changes in FFR, CFR and IMR post PCI of target vessels will also be recorded.
Sponsors
Ottawa Heart Institute Research Corporation
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Diabetic patients with angina and/or evidence of myocardial ischemia (includes ACS patients but not STEMI) * Willing and able to provide informed, written consent * Diabetic patients with clinically indicated, abnormal PET scan * Single or double vessel disease with coronary stenosis ≥50% referred for PCI
Exclusion criteria
* Significant left main stenosis ≥50% and/or triple vessel disease referred for CABG * Recent STEMI (\<5 days) * Previous CABG * LVEF ≤ 30% or cardiogenic shock * Complex coronary anatomy preventing FFR/CFR measurement
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of number of vessels fulfilling each of 4 permutations of fractional flow reserve (FFR) and coronary flow reserve (CFR) ie FFR ≤0.80 CFR ≥2.0, FFR ≤0.80 CFR <2.0, FFR >0.80 CFR ≥2.0 and FFR >0.80 CFR <2.0. | Duration of procedure in the catheterization laboratory ie 1 day | This is primarily an observational pilot study where coronary physiology is obtained at the time of the percutaneous coronary intervention (PCI) of the target vessel. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in FFR in target vessel | Baseline and post PCI | FFR will be measured pre and post PCI of target vessel |
| Change in CFR in target vessel | Baseline and post PCI | CFR will be measured pre and post PCI of target vessel |
| Change in index of microvascular resistance (IMR) in target vessel | Baseline and post PCI | IMR will be measured pre and post PCI of target vessel |
Countries
Canada
Outcome results
None listed